SweetValueLab
Write for us

NVIDIA Corporation — Wall Street Analyst Estimates & Price Targets

NVDA
NASDAQTechnologySemiconductorsCIK 0001045810nvidia.comAbout NVDA
Last close · Oct 16, 2026214.13−3.10 (−1.43%)
Market cap$5.2T

20 firms' latest targets, last 90 days: median $317.50 ($210.00–$515.00), 48% above the last close.

Price and published targets

daily close, 12 months · each dot a target, a firm's latest darker
$200$300$400$500NovJan 2026MarMayJulSep2025-10-28 · Wolfe Research: $2302025-10-29 · Mizuho Securities: $2352025-10-29 · UBS: $2352025-10-29 · Melius Research: $3002025-10-29 · Evercore ISI: $2612025-10-29 · D.A. Davidson: $2502025-10-30 · New Street: $3072025-10-31 · Goldman Sachs: $2402025-11-03 · Loop Capital Markets: $3502025-11-14 · Wells Fargo: $2652025-11-20 · Raymond James: $2722025-11-20 · Jefferies: $2502025-11-20 · Baird: $2752025-11-20 · Evercore ISI: $3522025-11-20 · Susquehanna: $2502025-11-20 · Morgan Stanley: $2352025-11-20 · Mizuho Securities: $2452025-11-20 · Bernstein: $2752025-11-20 · Barclays: $2752025-11-20 · KeyBanc: $2752025-11-20 · Deutsche Bank: $2152025-12-01 · Morgan Stanley: $2502025-12-01 · Seaport Global: $1402025-12-18 · Tigress Financial: $3502025-12-19 · Truist: $2752026-01-08 · Stifel: $2502026-01-09 · Mizuho Securities: $2752026-01-14 · RBC Capital: $2402026-01-16 · Jefferies: $2752026-02-11 · UBS: $2452026-02-23 · UBS: $4002026-02-24 · HSBC: $3102026-02-25 · Goldman Sachs: $2502026-02-26 · RBC Capital: $2502026-02-26 · Fundamental Research: $2182026-03-02 · Baird: $3002026-03-02 · Morgan Stanley: $2602026-03-03 · Wedbush: $3002026-03-05 · Tigress Financial: $3602026-03-12 · William Blair: $3002026-05-12 · Susquehanna: $2752026-05-12 · Wells Fargo: $3152026-05-14 · UBS: $2752026-05-14 · Cantor Fitzgerald: $3502026-05-18 · Morgan Stanley: $2852026-05-18 · KeyBanc: $3002026-05-19 · HSBC: $3252026-05-21 · Truist: $3072026-05-21 · Wedbush: $3302026-05-21 · Argus Research: $2702026-05-21 · Goldman Sachs: $2852026-05-21 · UBS: $2802026-05-21 · Baird: $5002026-05-21 · Evercore ISI: $4132026-05-21 · Needham: $2702026-05-21 · Melius Research: $4002026-05-21 · KeyBanc: $3102026-05-21 · RBC Capital: $2802026-05-21 · RBC Capital: $2702026-05-21 · RBC Capital: $3152026-05-21 · Morgan Stanley: $2882026-05-21 · Wolfe Research: $2752026-05-21 · Raymond James: $3302026-05-21 · Mizuho Securities: $3002026-05-21 · Stifel: $2822026-05-27 · Tigress Financial: $4252026-06-02 · Wells Fargo: $1392026-07-14 · KeyBanc: $3302026-08-20 · BMO Capital: $3402026-08-20 · Oppenheimer: $2652026-08-20 · RBC Capital: $3002026-08-21 · D.A. Davidson: $3352026-08-25 · Raymond James: $3522026-08-27 · Truist: $3462026-08-27 · D.A. Davidson: $3002026-08-27 · RBC Capital: $3302026-08-27 · Needham: $3002026-08-27 · Evercore ISI: $4652026-08-27 · Raymond James: $5152026-08-27 · UBS: $3002026-08-27 · Morgan Stanley: $3002026-08-27 · Oppenheimer: $3152026-08-27 · Stifel: $3152026-08-27 · Rosenblatt Securities: $3902026-08-27 · Bernstein: $4002026-08-27 · Goldman Sachs: $3002026-08-27 · Melius Research: $4202026-08-27 · Mizuho Securities: $3152026-08-27 · Macquarie: $3202026-09-09 · Piper Sandler: $3002026-10-02 · Morgan Stanley: $2302026-10-02 · Wells Fargo: $2102026-10-05 · BNP Paribas Exane: $345
$200$300$400$500NovFebMayAug

Each firm's latest target

last 90 days · 20 firms
DateFirmTargetPreviousChangeVs price thenVs price now
2026-10-05BNP Paribas Exane$345.00——+46%+61%
2026-10-02Morgan Stanley$230.00$300.00▼ 23%+0%+7%
2026-10-02Wells Fargo$210.00$139.00▲ 51%-9%-2%
2026-09-09Piper Sandler$300.00——+34%+40%
2026-08-27Truist$346.00$307.00▲ 13%+53%+62%
2026-08-27D.A. Davidson$300.00$335.00▼ 10%+33%+40%
2026-08-27RBC Capital$330.00$300.00▲ 10%+46%+54%
2026-08-27Needham$300.00$270.00▲ 11%+34%+40%
2026-08-27Evercore ISI$465.00$413.00▲ 13%+122%+117%
2026-08-27Raymond James$515.00$352.00▲ 46%+146%+141%
2026-08-27UBS$300.00$280.00▲ 7%+43%+40%
2026-08-27Oppenheimer$315.00$265.00▲ 19%+50%+47%
2026-08-27Stifel$315.00$282.00▲ 12%+50%+47%
2026-08-27Rosenblatt Securities$390.00——+86%+82%
2026-08-27Bernstein$400.00$275.00▲ 45%+91%+87%
2026-08-27Goldman Sachs$300.00$285.00▲ 5%+43%+40%
2026-08-27Melius Research$420.00$400.00▲ 5%+100%+96%
2026-08-27Mizuho Securities$315.00$300.00▲ 5%+50%+47%
2026-08-27Macquarie$320.00——+53%+49%
2026-08-20BMO Capital$340.00——+57%+59%

Consensus estimates

revenue and EPS by fiscal year · reported years marked
FYRevenueYoYEPSYoYRevenue rangeEPS rangeAnalysts
2024reported$60.9B+126%$1.19+600%est. $59.3B+3%est. $1.2428
2025reported$130.5B+114%$2.94+147%est. $129.4B+1%est. $2.9534
2026reported$215.9B+65%$4.90+67%est. $213.7B+1%est. $4.6934
2027$409.8B+90%$9.28+98%$371.3B–$423.5B$9.04–$9.7441
2028$694.6B+70%$15.77+70%$519.1B–$751.7B$13.66–$17.3042
2029$924.4B+33%$21.41+36%$613.8B–$1.2T$13.88–$27.1638
2030$1.1T+20%$25.60+20%$868.8B–$1.3T$18.45–$29.9430
2031$1.2T+5%$26.60+4%$911.6B–$1.3T$19.17–$31.1035
A reported year shows the company's figures, with the consensus beside it (revenue against it in %). Reported EPS is GAAP diluted; the analysts' EPS usually leaves items such as stock compensation out, so the two are not like for like. Faded: a year the valuation models do not read — they read the first 3, and a later one only while 10 or more analysts cover every year up to it — or one under 5 analysts.

Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.